Effects of Livagen and Epitalon, New Peptide Bioregulators, on Enkephalin-Degrading Enzymes from Human Serum

Abstract

The effects of new peptide bioregulators—Livagen (Lys-Glu-Asp-Ala) and Epitalon (Ala-Glu-Asp-Gly)—on the endogenous opioid system was studied. In particular, attention was focused on their ability to change the activity of enkephalin-degrading enzymes of blood serum and interact with opioid receptors of the brain membrane fraction. Enkephalinase activity was assayed in vitro by the rate of 3H-Leu-enkephalin hydrolysis in the presence of Livagen and Epitalon. These peptides inhibited enkephalin-degrading enzymes of human serum. Livagen proved to be more efficient than some well-known peptidase inhibitors, such as puromycin, leupeptin, and D-PAM. The dose–inhibitory effect curves for Livagen and Epitalon were plotted; their IC50 equaled 20 and 500 μM, respectively. The interaction between the peptides and opioid receptors was estimated using a radioreceptor method with [3H][D-Ala2, D-Leu5]-enkephalin. No interaction was observed between the peptides and μ- or δ-opioid receptors of the membrane fraction from the rat brain.

This is a preview of subscription content, access via your institution.

REFERENCES

  1. Ashmarin, I.P., Stukalov, P.V., and Eshchenko, N.D., Biokhimiya mozga (Biochemistry of the Brain), St. Petersburg: St. Petersburg Univ., 1999.

    Google Scholar 

  2. Brodskii, V.Ya, Khavinson, V.Kh., Zolotarev, Yu.A., Nechaeva, N.V., Malinin, V.V., Novikova, T.E., Gvazava, I.G., and Fateeva, V.I., Effect of Peptides on the Rhythm of Protein Synthesis in Hepatocyte Cultures of Rats of Different Age, Izv. Ross. Akad. Nauk. Ser. Biol., 2001, no. 5, pp. 517-521.

    Google Scholar 

  3. Gomazkov, O.A., Funktsional'naya biokhimiya regulyatornykh peptidov (Functional Biochemistry of Regulatory Peptides), Moscow: Nauka, 1993.

    Google Scholar 

  4. Khavinson, V.Kh., RF Patent 2157233, 2000.

  5. Khavinson, V.Kh., RF Patent 2161501, 2001.

  6. Kost, N.V., Sokolov, O.Yu., Gabaeva, M.V., Grivennikov, I.A., Andreeva, L.A., Myasoedov, N.F., and Zozulya, A.A., Inhibitory Effect of Semax and Selank on Enkephalin-Degrading Enzymes from Human Blood Serum, Bioorg. Khim., 2001, no. 3, pp. 180-183.

    Google Scholar 

  7. Lishmanov, Yu.V. and Maslov, L.N., Opioidnye neiropeptidy, stress i adaptatsionnaya zashchita serdtsa (Opioid Neuropeptides, Stress, and Adaptational Cardioprotection), Tomsk: Tomsk Univ., 1994.

    Google Scholar 

  8. Marini, M., Roscetti, G., Bonjionio, L., Urbani, A., and Rodo, L., Hydrolysis and Protection from Hydrolysis of Enkephalins in Human Plasma, Neurochem. Res., 1990, vol. 15, pp. 61-67.

    Google Scholar 

  9. Simantov, R., Childes, S.R., and Snyder, S.H., The Opiate Receptor Binding Interactions of 3H-Methionine-Enkephalin, an Opioid Peptide, Eur. J. Pharmacol., 1978, vol. 47, no.3, pp. 319-331.

    Google Scholar 

  10. Sokolov, O.Yu, Gabaeva, M.V., Gurevich, K.G., Akatova, E.V., Alfimova, M.V., and Kost, N.V., Total Enkephalinase Activity Assay in Human Blood Plasma, Neirokhimiya, 2000, vol. 17, no.2, pp. 150-156.

    Google Scholar 

  11. Zolotarev, Yu.A., Dorokhova, E.M., Nezavibatko, V.N., et al., The Solid-State Catalytic Synthesis of Tritium Labelled Amino Acids, Peptides, and Proteins, Amino Acids, 1995, vol. 8, pp. 353-365.

    Google Scholar 

  12. Zozulya, A.A., Shchurin, M.R., Dikaya, V.I., Bondar', V.V., Krym, N.M., and Panteleeva, G.P., Effect of Dalargin on the Opioid and Immune Systems of Patients with Depressive Syndrome, Zh. Nevropatol. Psikhiatr., 1994, vol. 94, no.1, pp. 61-63.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kost, N.V., Sokolov, O.Y., Gabaeva, M.V. et al. Effects of Livagen and Epitalon, New Peptide Bioregulators, on Enkephalin-Degrading Enzymes from Human Serum. Biology Bulletin 30, 351–353 (2003). https://doi.org/10.1023/A:1024809822681

Download citation

Keywords

  • Peptide
  • Human Serum
  • Blood Serum
  • Opioid Receptor
  • Membrane Fraction